Costs of Severe to Profound Hearing Loss & Cost Savings of Cochlear Implants

Ivette Cejas,David H. Barker,Esteban Petruzzello,Christina M. Sarangoulis,Alexandra L. Quittner

DOI: https://doi.org/10.1002/lary.31497

IF: 2.97

2024-05-16

The Laryngoscope

Abstract:This study estimated costs of severe to profound hearing loss, including costs and cost‐savings associated with cochlear implantation. The estimated lifetime cost of an individual born with severe to profound hearing loss is 37 billion. Objective To estimate costs of severe to profound hearing loss, including costs and cost‐savings associated with cochlear implantation. Methods Data was obtained from the National Health Interview Survey, the National Health and Nutrition Examination Survey and national Medicare rates. We used continuous time state transition models with individual patient simulations to estimate the costs of severe to profound hearing loss (SPHL) across the lifespan. The model included four states, normal hearing, severe to profound hearing loss, cochlear implantation, and death. Results The estimated lifetime cost of an individual born with SPHL is 390,931 [311,976; 471,475], compared to those who are not implanted 154,536 [7,093; 302,936]. The annual societal costs for the US population were estimated to be $37 [8; 187] billion. Conclusions SPHL is a costly condition, with the primary driver being lost productivity. Medical costs were higher for cochlear implantation, however, the higher income earnings offset the higher medical costs. Overall, early implantation substantially reduced lifetime costs. Access to hearing health care and technology is critical given the documented benefits for language, education, and quality of life. Government and insurance policies should be modified to allow for equal access and coverage for hearing technology, which will ultimately reduce lifetime and societal costs. Levels of Evidence: N/A The current study used existing nationally representative datasets. Thus, these levels of evidence do not apply. Laryngoscope, 2024

medicine, research & experimental,otorhinolaryngology